GLPwatch
Attempted suicide with liraglutide overdose did not induce hypoglycemia.
Diabetes Res Clin Pract · 2013
Last updated 2026-05-28A 33-year-old woman with type 2 diabetes injected 72 mg of liraglutide in a suicide attempt. She experienced gastrointestinal side effects but did not develop low blood sugar.
AI summary of the abstract below.
| Journal | Diabetes Res Clin Pract, 2013 |
|---|---|
| Citations | 21 |
| Relative citation ratio | 0.78 |
| NIH percentile | 42 |
| Molecules | liraglutide |
Abstract
We document the first reported case of attempted suicide with the GLP-1 receptor agonist, liraglutide: a 33-year-old Japanese woman with type 2 diabetes reported subcutaneously injected 72 mg of liraglutide. She experienced gastrointestinal symptoms but no hypoglycemia.
Verbatim abstract via PubMed 23149376 ↗
Related research
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.
- Liraglutide and Renal Outcomes in Type 2 Diabetes.
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
- Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.
- The Discovery and Development of Liraglutide and Semaglutide.